This month's microlearning delves into how laboratories can leverage kaizen events to seize continuous improvement opportunities. Questions? Contact us: mcleducation@mayo.edu
This month's microlearning explores the significant impact of psychological safety on employees in the workplace.
This month's microlearning delves into the understanding that everyone experiences mental health, highlighting key indicators to watch for and effective strategies for support.
This month’s microlearning shares how compassionate leadership can foster trust, collaboration, and growth within your team, leading to greater productivity and satisfaction.
The CORE communication approach, designed by Mayo Clinic Experience Training, Education & Coaching, is a foundational method to help navigate human-centered communication that emphasizes perspective-taking, growth in learning, and positive behavior changes.
Staff retention is a critical factor in achieving organizational success, providing continuity, stability, and preserving institutional knowledge within a company.
This "Specialty Testing" webinar describes a new serum test for bile acid malabsorption. Descriptions illustrate how the test can be used as a screening test and as a tool for therapeutic action.
As a senior principal developer for the brand-new Process Innovation Through Automation Laboratory, Brian Dukek helps labs throughout the Department of Laboratory Medicine and Pathology evaluate new automation tools and streamline automation workflows.
As a national accounts executive for Mayo Clinic Laboratories, Kimberly Knight helps clients see and understand the importance of laboratory testing and how partnering with Mayo Clinic Laboratories on that testing can help them and their patients.
Mayo Clinic Laboratories is committed to working with our communities as we all face the unprecedented challenges of the COVID-19 pandemic. Since early 2020, Mayo Clinic researchers and experts have provided expertise to guide the public health response, and our clinical staff has been on the front lines providing lifesaving care for patients with COVID-19.
Matt Millen, ex-pro NFL player, who played on four Super Bowl-winning teams underwent a nearly six-year medical journey in search for answers. Finally, he was diagnosed with amyloidosis using a new testing methodology at Mayo Clinic.
Understanding the difference between benign and malignant adrenal tumors has always been difficult, but the new Urinary Steroid Profile assay will assist with this medical challenge.
Newborn screening panels that test for a variety of conditions are available in every state; however, test performance and response rate by each state are very different. Mayo Clinic's Biochemical Genetics Laboratory created the Collaborative Laboratory Integrated Reports tool to mitigate the national (and international) problem of false positives and to raise the bar on test performance.